CSL Behring is a leading global biotherapeutics company with a broad range of innovative plasma-derived and recombinant therapies. For over a century, we have been driven by our promise to save lives. Today, our therapies include those to treat coagulation disorders, primary immune deficiencies, and hereditary angioedema among others.
1020 First Ave.
King of Prussia, Pennsylvania 19406